LIPOCINE INC. Accrued Liabilities, Current
LIPOCINE INC. (LPCN) had Accrued Liabilities, Current of $1.07 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-04
- 2026-06-30: Accrued Liabilities, Current $1.07M.
- 2026-03-31: Accrued Liabilities, Current $645.12K.
- 2025-12-31: Accrued Liabilities, Current $1.24M.
- 2025-09-30: Accrued Liabilities, Current $749.67K.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $1.07M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $645.12K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.24M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $749.67K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $685.78K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $619.41K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $921.24K 10-K · filed 2026-03-10 |
| 2024-09-30 | $1.29M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.23M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $761.47K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.22M 10-K · filed 2025-03-13 |
| 2023-09-30 | $1.14M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.31M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.13M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.08M 10-K · filed 2024-03-07 |
| 2022-09-30 | $880.85K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $899.30K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $567.90K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $1.02M 10-K · filed 2023-03-10 |
| 2021-09-30 | $1.57M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.44M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.50M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.65M 10-K · filed 2022-03-09 |
| 2020-09-30 | $1.53M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $993.26K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $738.28K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $449.30K 10-K · filed 2021-03-11 |
| 2019-09-30 | $540.95K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $993.46K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $426.19K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $487.13K 10-K · filed 2020-03-13 |
| 2018-09-30 | $488.63K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $886.98K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $305.06K 10-Q · filed 2018-05-07 |
| 2017-12-31 | $1.50M 10-K · filed 2019-03-06 |
| 2017-09-30 | $1.68M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.79M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $1.49M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $1.08M 10-K · filed 2018-03-12 |
| 2016-09-30 | $707.30K 10-Q · filed 2016-11-08 |
| 2016-06-30 | $1.60M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.92M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $2.88M 10-K · filed 2017-03-06 |
| 2015-09-30 | $1.72M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $1.27M 10-Q · filed 2015-08-11 |
| 2015-03-31 | $957.78K 10-Q · filed 2015-05-07 |
| 2014-12-31 | $1.33M 10-K · filed 2016-03-10 |
| 2014-09-30 | $1.66M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $1.03M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $727.05K 10-Q · filed 2014-05-13 |
| 2013-12-31 | $256.75K 10-K · filed 2015-03-11 |
| 2013-09-30 | $144.98K 10-Q · filed 2013-11-13 |
| 2012-12-31 | $107.95K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |